NCT04338438View on ClinicalTrials.gov

Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

January 31, 2020

Conditions
Gastric Cancer
Interventions
DRUG

Apatinib Mesylate tablets combined with S-1 capsules

Apatinib Mesylate tablets combined with S-1 capsules, p.o.

All Listed Sponsors
lead

Beijing Friendship Hospital

OTHER

NCT04338438 - Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer | Biotech Hunter | Biotech Hunter